These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 20154652)

  • 1. Hospitalization costs associated with hypertension as a secondary diagnosis.
    Arredondo A
    Am J Hypertens; 2010 Mar; 23(3):224. PubMed ID: 20154652
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical importance of direct hospital costs in patients with arterial hypertension in a university hospital, Rio de Janeiro, Brazil].
    de Souza e Silva NA; Aguiar GR; Nogueira Ada R; Duarte MM; Alves RH
    Rev Saude Publica; 1986 Aug; 20(4):293-302. PubMed ID: 3576101
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of diagnostic costs for hospitalized and ambulatory hypertension patients.
    Bair CW; Anderson MC; McNamara MJ
    Inquiry; 1981; 18(1):37-45. PubMed ID: 6453090
    [No Abstract]   [Full Text] [Related]  

  • 4. Hospitalization costs associated with hypertension as a secondary diagnosis among insured patients aged 18-64 years.
    Wang G; Zhang Z; Ayala C
    Am J Hypertens; 2010 Mar; 23(3):275-81. PubMed ID: 20010701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The identifier concept: clinical parameters to stratify hospital patient costs for patients with hypertension.
    Muñoz E; Birnbaum E; Chalfin D; Mulloy K; Goldstein J; Wise L
    Heart Lung; 1988 Sep; 17(5):550-4. PubMed ID: 3138204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of health costs associated with treatment of hypertension with a calcium channel blocker and angiotensin-converting enzyme inhibitor in the United States and Japan.
    Sakamaki Y; Sasamura H; Ikeda S; Ikegami N; Saruta T
    Hypertens Res; 2006 May; 29(5):333-8. PubMed ID: 16832153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ambulatory blood pressure monitoring: is it cost-effective?
    Krakoff LR; Schechter C; Fahs M; Andre M
    J Hypertens Suppl; 1991 Dec; 9(8):S28-30. PubMed ID: 1795198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expenses concerning evaluation and treatment of hypertension.
    Kringsholm B; Hilden T
    Acta Med Scand Suppl; 1979; 626():47-50. PubMed ID: 285594
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cost of care of arterial hypertension and its impact on the budget assigned to health in Mexico].
    Villarreal-Ríos E; Mathew-Quiroz A; Garza-Elizondo ME; Núñez-Rocha G; Salinas-Martínez AM; Gallegos-Handal M
    Salud Publica Mex; 2002; 44(1):7-13. PubMed ID: 11910723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct medical costs of bronchiolitis hospitalizations in the United States.
    Pelletier AJ; Mansbach JM; Camargo CA
    Pediatrics; 2006 Dec; 118(6):2418-23. PubMed ID: 17142527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis of hypertension, an update--efficient and cost-saving].
    Zidek W
    MMW Fortschr Med; 2004 May; 146(19):43, 45-6. PubMed ID: 15357479
    [No Abstract]   [Full Text] [Related]  

  • 12. Estimating hospital costs by diagnosis group.
    Restuccia JD; Murphy DV
    Inquiry; 1980; 17(2):155-64. PubMed ID: 6448227
    [No Abstract]   [Full Text] [Related]  

  • 13. Economic burden of comorbidities in patients with psoriasis is substantial.
    Kimball AB; Guérin A; Tsaneva M; Yu AP; Wu EQ; Gupta SR; Bao Y; Mulani PM
    J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):157-63. PubMed ID: 20561129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of care of the hypertensive in the primary preventive trial, Gothenburg.
    Wilhelmsen L; Berglund G; Wedel H
    Acta Med Scand Suppl; 1979; 626():44-6. PubMed ID: 285593
    [No Abstract]   [Full Text] [Related]  

  • 15. [Financial requirements for health services demands for diabetes and hypertension in Mexico: 2001-2003].
    Arredondo A
    Rev Invest Clin; 2001; 53(5):422-9. PubMed ID: 11795108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multidimensional analysis of the impact of high-cost hospitalization.
    Fleming ST; Kobrinski EJ; Long MJ
    Inquiry; 1985; 22(2):178-87. PubMed ID: 3159673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the pharmacological treatment of mild to moderate hypertension cost effective in stroke prevention?
    Malcolm LA; Kawachi I; Jackson R; Bonita R
    N Z Med J; 1988 Apr; 101(843):167-71. PubMed ID: 3128747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs.
    Dragomir A; Côté R; Roy L; Blais L; Lalonde L; Bérard A; Perreault S
    Med Care; 2010 May; 48(5):418-25. PubMed ID: 20393367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic analysis of a tailored behavioral intervention to improve blood pressure control for primary care patients.
    Datta SK; Oddone EZ; Olsen MK; Orr M; McCant F; Gentry P; Bosworth HB
    Am Heart J; 2010 Aug; 160(2):257-63. PubMed ID: 20691830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.